All Resources

Corneal crosslinking for Keratoconus and other corneal thinning disorders

Description

Corneal thinning disorders are rare progressive disorders that can either be caused by a primary disease process (keratoconus) or may be secondary to another process; such as post... More ≫

Description

Corneal thinning disorders are rare progressive disorders that can either be caused by a primary disease process (keratoconus) or may be secondary to another process; such as post laser-in-situ-keratomileusis (LASIK) induced keratectasia (KE). It has been estimated that the most common corneal thinning disorder, keratoconus (KC), affects 1 in every 2000 people globally. Corneal crosslinking using riboflavin and ultraviolet-A radiation (CXL) is an emerging technology which may be used for managing corneal thinning disorders. The purpose of this review is to determine the safety, clinical efficacy, social impact and economic value of CXL for the management of corneal thinning disorders.

Tags